SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $114,000 | -79.2% | 1,168 | -80.2% | 0.00% | -66.7% |
| Q4 2014 | $547,000 | +202.2% | 5,894 | +124.4% | 0.00% | +200.0% |
| Q3 2014 | $181,000 | -77.4% | 2,627 | -72.8% | 0.00% | -66.7% |
| Q1 2014 | $802,000 | +317.7% | 9,662 | +218.9% | 0.00% | +200.0% |
| Q3 2013 | $192,000 | – | 3,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|